Bifido비피도
238200 · KOSDAQ · ₩238200 · 비피도
₩2,470▲ ₩85 (3.56%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩20B | ₩12B | ₩19B | ₩15B | ₩12B |
| Cost of sales | ₩12B | ₩9.1B | ₩11B | ₩8.7B | ₩8B |
| Gross profit | ₩7.5B | ₩3.3B | ₩7.4B | ₩5.9B | ₩4.1B |
| Operating income | ₩1.4B | −₩4.5B | −₩344M | ₩1.3B | −₩1B |
| Net income | −₩193M | −₩5.4B | ₩1.1B | ₩1.5B | ₩4.5B |
| Net income to shareholders | −₩193M | −₩5.4B | ₩1.1B | ₩1.5B | ₩4.5B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩61B | ₩61B | ₩72B | ₩55B | ₩55B |
| Current assets | ₩38B | ₩23B | ₩37B | ₩24B | ₩25B |
| Cash and equivalents | ₩7.7B | ₩1.8B | ₩5.8B | ₩849M | ₩4.5B |
| Total liabilities | ₩15B | ₩15B | ₩20B | ₩2.4B | ₩4B |
| Current liabilities | ₩15B | ₩14B | ₩20B | ₩1.9B | ₩3.6B |
| Borrowings | ₩12B | ₩11B | ₩11B | ₩1.1B | ₩775M |
| Total equity | ₩46B | ₩47B | ₩52B | ₩52B | ₩51B |
| Shareholders' equity | ₩46B | ₩47B | ₩52B | ₩52B | ₩51B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩4B | −₩716M | ₩2.8B | ₩1.9B | ₩2B |
| Capital spending | ₩7.2B | ₩6.1B | ₩3.3B | — | — |
| Free cash flow | −₩3.2B | −₩6.8B | −₩443M | ₩1.9B | ₩2B |
Consolidated where available. Amounts in won.
Also known as: Bifido / 비피도 / 238200 / KRX:238200
Source: KRX statistical information